LIWANLI Innovation Co., Ltd. (TPE:3054)
Taiwan · Delayed Price · Currency is TWD 65.00
+0.40 (0.62%)
Mar 26, 2026, 1:30 PM CST
LIWANLI Innovation Market Cap
LIWANLI Innovation has a market cap or net worth of 5.24 billion as of March 26, 2026. Its market cap has increased by 193.45% in one year.
Market Cap
5.24B
Enterprise Value
4.80B
Revenue
125.54M
Ranking
n/a
PE Ratio
33.51
Stock Price
65.00
Market Cap Chart
Since April 23, 2003, LIWANLI Innovation's market cap has increased from 1.72B to 5.24B, an increase of 204.21%. That is a compound annual growth rate of 4.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 5.24B | 100.31% |
| Dec 31, 2025 | 2.62B | 31.64% |
| Dec 31, 2024 | 1.99B | 17.38% |
| Dec 29, 2023 | 1.69B | 5.26% |
| Dec 30, 2022 | 1.61B | -23.52% |
| Dec 30, 2021 | 2.10B | 5.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Handa Pharmaceuticals | 10.98B |
| Formosa Laboratories | 6.65B |
| Orient Pharma | 6.55B |
| SCI Pharmtech | 6.25B |
| Easywell Biomedicals | 4.69B |
| Orient EuroPharma | 4.14B |
| Merdury Biopharmaceutical | 3.39B |
| Maywufa Company | 2.90B |